SSA
TECH icon

Schonfeld Strategic Advisors’s Bio-Techne TECH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.3M Buy
+75,000
New +$4.05M 0.02% 629

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Schonfeld Strategic Advisors's TECH Position: Q2 2026 in Review

Schonfeld Strategic Advisors increased its Bio-Techne (TECH) stake by 313% in Q2 2026, buying an estimated $2.4M and bringing the position to 58,700 shares worth $4.15M. The position accounts for 0.01% of the portfolio, ranked #722.

Schonfeld Strategic Advisors first reported a position in TECH in Q1 2017 and has held it in 16 quarters since. The position peaked at $15.3M in Q1 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Schonfeld Strategic Advisors held 58,700 shares of Bio-Techne worth $4.15M as of Q2 2026.
  • Schonfeld Strategic Advisors bought 44,503 Bio-Techne shares in Q2 2026, an estimated $2.4M.
  • Bio-Techne made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #722 holding.
  • Schonfeld Strategic Advisors first reported a position in Bio-Techne in Q1 2017 and has held it in 16 quarters since.
  • Schonfeld Strategic Advisors's Bio-Techne position peaked at $15.3M in Q1 2025.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.